Ledger.Open graph →
SEC Form D · filed October 3, 2022

EnPlusOne Biosciences Inc

Offering
$12.4M
Sold
$11.9M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WATERTOWN, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (5)

J. Riggs · Santiago, F3DirectorGreg Rudin · Pittsburgh, PADirectorTodd R. Riecke · Covington, LAExec · DirectorR. Harker · ENGLEWOOD CLIFFS, NJExec · DirectorWilliam Douglas · Elkhorn, NEDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗